Dupont Capital Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-131,529
| Closed | -$13.1M | – | 1346 |
|
|
2019
Q3 | $13.1M | Sell |
131,529
-4,096
| -3% | -$389K | 0.3% | 55 |
|
|
2019
Q2 | $12.5M | Sell |
135,625
-22,435
| -14% | -$2.13M | 0.29% | 67 |
|
|
2019
Q1 | $14.9M | Buy |
158,060
+19,658
| +14% | +$1.72M | 0.34% | 50 |
|
|
2018
Q4 | $8.87M | Sell |
138,402
-65,732
| -32% | -$4.85M | 0.22% | 80 |
|
|
2018
Q3 | $18.3M | Buy |
204,134
+23,307
| +13% | +$2.06M | 0.4% | 41 |
|
|
2018
Q2 | $14.4M | Buy |
180,827
+1,544
| +0.9% | +$128K | 0.34% | 53 |
|
|
2018
Q1 | $16M | Sell |
179,283
-30,369
| -14% | -$2.92M | 0.39% | 43 |
|
|
2017
Q4 | $21.9M | Buy |
209,652
+10,094
| +5% | +$1.14M | 0.5% | 27 |
|
|
2017
Q3 | $29.1M | Sell |
199,558
-4,232
| -2% | -$576K | 0.66% | 19 |
|
|
2017
Q2 | $26.5M | Buy |
203,790
+26,038
| +15% | +$3.19M | 0.59% | 22 |
|
|
2017
Q1 | $22.1M | Sell |
177,752
-44,244
| -20% | -$5.29M | 0.49% | 32 |
|
|
2016
Q4 | $25.7M | Buy |
221,996
+4,791
| +2% | +$534K | 0.57% | 24 |
|
|
2016
Q3 | $22.7M | Buy |
217,205
+54,197
| +33% | +$5.87M | 0.51% | 26 |
|
|
2016
Q2 | $16.1M | Sell |
163,008
-6,508
| -4% | -$673K | 0.36% | 53 |
|
|
2016
Q1 | $17M | Buy |
169,516
+14,200
| +9% | +$1.46M | 0.39% | 54 |
|
|
2015
Q4 | $18.6M | Sell |
155,316
-61,639
| -28% | -$7.13M | 0.45% | 41 |
|
|
2015
Q3 | $23.5M | Sell |
216,955
-117,687
| -35% | -$14.6M | 0.59% | 33 |
|
|
2015
Q2 | $38.7M | Sell |
334,642
-11,461
| -3% | -$1.31M | 0.84% | 22 |
|
|
2015
Q1 | $39.9M | Sell |
346,103
-108,703
| -24% | -$13M | 0.78% | 21 |
|
|
2014
Q4 | $50.9M | Sell |
454,806
-41,689
| -8% | -$4.4M | 0.94% | 21 |
|
|
2014
Q3 | $47.1M | Sell |
496,495
-42,745
| -8% | -$3.86M | 0.82% | 19 |
|
|
2014
Q2 | $46.3M | Buy |
539,240
+80,374
| +18% | +$6.11M | 0.76% | 23 |
|
|
2014
Q1 | $32M | Buy |
458,866
+40,670
| +10% | +$3.22M | 0.52% | 31 |
|
|
2013
Q4 | $35.3M | Sell |
418,196
-18,734
| -4% | -$1.48M | 0.62% | 25 |
|
|
2013
Q3 | $33.6M | Buy |
436,930
+90,468
| +26% | +$6.34M | 0.62% | 23 |
|
|
2013
Q2 | $20.3M | Buy |
+346,462
| New | +$20.8M | 0.38% | 56 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Dupont Capital Management's CELG Position: Q4 2019 in Review
Dupont Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 131,529 shares — an estimated $13.1M sold.
Dupont Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $50.9M in Q4 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Dupont Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Dupont Capital Management sold 131,529 Celgene Corp shares in Q4 2019, an estimated $13.1M.
- Dupont Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Dupont Capital Management's Celgene Corp position peaked at $50.9M in Q4 2014.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Dupont Capital Management's 13F filing for Q4 2019, filed 27 Jan 2020.